Milestone Approval of Invasive Brain-Computer I...

By João L. Carapinha

March 20, 2026

China's National Medical Products Administration (NMPA) has approved the world's first invasive brain-computer interface medical device for market entry. Develope...
Accelerating Patient Access: MHRA NICE Alignment Initiative
Long-Term HPV Vaccine Effectiveness: Sustained Protection Against Cervical Di...
PRIME Scheme Evaluation: Insights from Enhanced Development Tools Pilot
EU Approves Imfinzi Gastric Cancer Treatment as Perioperative Immunotherapy
Europe Life Sciences Competitiveness: Addressing Decline and Unlocking Potential
EU Medicines Regulation Achievements: EMA’s 2025 Highlights and Future ...
Catalyzing Cardiovascular Health Innovation through Urban Interventions and C...
EMA Approval Submission for Teclistamab Multiple Myeloma Monotherapy
Enhertu Early Breast Cancer: FDA Priority Review for Reducing Recurrence Risk
EMA’s Clinical Trials Guidance for Enhancing Flexibility During Public ...
Portugal Clinical Trials Regulation: A Comprehensive Framework for EU Complia...
Harmonizing Non-Clinical Evaluation of Microbiome Medicinal Products in the EU